Images
Participants
Contact
La Opinión de Zamora publishes an article on research conducted by Angel Rodríguez Nebreda, ICREA researcher at IRB Barcelona, on the functions of p53 in breast and colon tumours. Nebreda presented the results on the protein kinase p38 MAPKs in the Centro de Investigación del Cáncer de Salamanca.
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
